Navigation Links
CEL-SCI Corporation Releases Letter to Shareholders
Date:7/7/2009

VIENNA, Va., July 7 /PRNewswire-FirstCall/ -- The following letter is being released by CEL-SCI Corporation (NYSE Amex: CVM) to its shareholders:

Dear Fellow Shareholders:

Recently we have been hearing a great deal about the pandemic caused by the H1N1 swine flu. You may think to yourself, this is no big deal since it does not seem that serious and, look what happened to bird flu - it disappeared. Wrong - on both counts! In this letter I will show you where in the world, outside of the Far East, we already have a potent reservoir of bird flu just waiting to "meet" the swine flu. Once one person infected with a combined bird/swine flu virus gets on a plane, there will be no way to contain that next stage of the continuing pandemic. CEL-SCI scientists and their collaborators are in the process of trying to develop a vaccine/treatment for this eventuality.

Before I get into more details, I want to thank my fellow shareholders for supporting us during the past 9 months of the financial crisis. The crisis severely tested us and we have become better at what we do. In the process we have also defined CEL-SCI to work in three separate business units, all designed to support each other to make an enormous difference for the world and create financial success for our shareholders.

The three business units are:

1) Vaccines/treatment: H1N1 (swine) and other influenza viruses, as

well as a vaccine for rheumatoid arthritis.

2) Unique contract manufacturing services using our new manufacturing

facility near Baltimore, MD to generate additional revenue streams.

3) Our late-stage non-toxic cancer immunotherapy, Multikine, designed

to make the first cancer treatment more successful.

'/>"/>

SOURCE CEL-SCI Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. CEL-SCI to Present at the Noble Financial Conference
2. CEL-SCI CORPORATION Manufacturing Facility for Pivotal Phase III Cancer Trial Scheduled to Be Completed During 2008 Third Quarter
3. CEL-SCI Announces Exclusive Licensing Agreement with Teva for Cancer Drug Multikine
4. CEL-SCI CORPORATION Reports Third Quarter 2008 Financial Results
5. CEL-SCI Takes Delivery of New Manufacturing Facility
6. Updated Pictures of CEL-SCI Manufacturing Facility Available Online
7. CEL-SCI Corporation Releases Letter to Shareholders
8. CEL-SCI Corporation Announces 2008 Financial Results
9. CEL-SCI Corporation to Launch Aseptic Filling for Stem Cell Produced Therapies and Other Biological Products
10. CEL-SCI Presents Data at Prestigious Medical Conference Demonstrating That Its L.E.A.P.S. Technology Stimulates Maturation of Human Blood Cells Into Dendritic Cells Suggesting Potential for Prevention and Treatment of Infectious Disease
11. CEL-SCIs L.E.A.P.S. Technology Shows Potential to Treat Swine Influenza in Preclinical Studies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... 10, 2014 Terascala, the industry leader ... Alan Swahn, a former vice president of product management ... vice president of marketing. Terascala’s software when combined with ... create the highest performance and most reliable solutions for ... guide Terascala’s channel expansion and broaden its product portfolio. ...
(Date:7/10/2014)... 2014 Robert Harman, DVM, Founder and CEO ... proud to announce the relaunch of his highly informative blog, ... series called “ What are Stem Cells ?” Dr. ... straightforward foundation in the basics of stem cell therapy so ... right type of treatment when considering regenerative medicine. , A ...
(Date:7/10/2014)... 10, 2014 EvoDerma ’s NOOME Anti-Aging ... rejuvenating device now comes with a second treatment cup to ... , The new cup is thinner on the edges for ... target rough, thin and uneven surfaces on the face, neck ... a stimulating treatment on areas such as the cheeks and ...
(Date:7/10/2014)... 10, 2014  Franciscan St. Anthony Health-Crown ... for respiratory monitoring outside the operating room, ... in embracing state-of-the-art patient safety technology. ... breathing and can alert medical caregivers when ... amount of carbon dioxide the patient is ...
Breaking Biology Technology:Terascala Expands Executive Team 2Terascala Expands Executive Team 3Robert Harman, DVM Talks About What Stem Cells are in His Latest Blog Series for Vet-Stem, Inc. 2Robert Harman, DVM Talks About What Stem Cells are in His Latest Blog Series for Vet-Stem, Inc. 3Introducing a New Bonus Treatment Cup for EvoDerma’s NOOME Anti-Aging Motion 2Franciscan St. Anthony Health-Crown Point Underscores Patient Safety Commitment Through Expanded Use of Capnography 2
... To thrive in today,s,competitive and changing marketplace, sales ... performance doesn,t just happen. Productive,companies train, structure, deploy, ... field-performance to ensure high success rates., Best ... their sales forces to evolve and mature to ...
... Part Of Georgetown University Hospital Arsenal Against ... ... Sciences (OTC,Bulletin Board: DSCI), a provider of advanced wound care products,announced ... Leptospermum Honey, has been used by clinicians at Georgetown,University Hospital,s Wound ...
... Danube Pharmaceuticals, Inc., a,privately held biopharmaceutical company ... drugs for ophthalmology, is pleased,to announce the appointment ... Chief,Executive Officer., "I am honored and delighted ... its history as it advances its lead programs ...
Cached Biology Technology:Increasing Sales Productivity Through Superior Sales Force Performance Management 2Derma Sciences MEDIHONEY(TM) Helps to Save Patient's Limb 2Derma Sciences MEDIHONEY(TM) Helps to Save Patient's Limb 3Derma Sciences MEDIHONEY(TM) Helps to Save Patient's Limb 4Barrett Katz, MD, MBA, Named CEO of Danube Pharmaceuticals 2Barrett Katz, MD, MBA, Named CEO of Danube Pharmaceuticals 3
(Date:7/11/2014)... division of the striatum is also involved in ... of substance P in the striatal marginal division ... his team, College of Biophotonics, South China Normal ... P receptor, neurokinin 1 was highly expressed in ... rats. Unilateral or bilateral injection of an antisense ...
(Date:7/11/2014)... -- Research and Markets has announced the ... Industry Analysis Size Share Growth Trends and Forecast to ... http://photos.prnewswire.com/prnh/20130307/600769 The rising number ... for high level security in both private and public ... username and passwords, tokens etc. are vulnerable to attacks. ...
(Date:7/10/2014)... in New Mexico, nearly every public golf course is ... potable water supplies. Across the U.S. Southwest as a ... treated effluent. Reusing the effluent increases the sustainability of ... alike fertilize their lawns during the growing season. The ... State University turfgrass expert has a new vision for ...
Breaking Biology News(10 mins):International Biometrics Technology Market - Industry Analysis Size Share Growth Trends and Forecast to 2019 2'Tailored' water -- the latest in lawn care 2
... biologist at Fred Hutchinson Cancer Research Center, has received the ... Pfizer Inc., the award consists of a $25,000 prize in ... , She was among 18 honored by NAS this year ... the physical, biological and social sciences. , Biggins, a ...
... LA JOLLA, CA January 8, 2013 - Chemists at The ... one of the most fundamental tasks in molecular biology. Their new ... that these cells may be easily located and/or selected out from ... in a recent issue of the chemistry journal Angewandte Chemie ...
... Qubcois en Reproduction (RQR), Palais des congrs de Montral, Montral, ... Submissions: 15 February 2013 -- The Society for the ... for presentation at the 46th SSR Annual Meeting to be ... visit the SSR Meetings page ( http://www.ssr.org/Meetings.shtml ) for details; ...
Cached Biology News:National Academy of Sciences honors geneticist and biologist Sue Biggins 2Chemists devise inexpensive, benchtop method for marking and selecting cells 2Chemists devise inexpensive, benchtop method for marking and selecting cells 3
Donor feline serum and plasma...
8 different frozen tissues are mounted on positively charged glass slides...
... cups provide flexible sealing lips for ... surfaces. ,PFG: Flat cup ,PBG: Bellows ... Multiple Bellows cup , Range ... 200 mm , Multiple suction cup ...
XA7 B6...
Biology Products: